Phase II study of bevacizumab in combination with carboplatin plus paclitaxel as first-line chemotherapy for non-squamous non-small cell lung cancer with malignant pleural effusion

被引：0
|
作者：
Tamiya, M. [1 ]
Tamiya, A. [2 ]
Asami, K. [2 ]
Okishio, K. [3 ]
Kawagchi, T. [2 ]
Suzuki, H. [1 ]
Okamoto, N. [1 ]
Kawase, I. [1 ]
Atagi, S. [3 ]
Hirashima, T. [1 ]
机构：
[1] Osaka Prefectural Hosp Org, Osaka Prefectural Med Ctr, Habikino, Japan
[2] Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[3] Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3492
引用
收藏
页码：S826 / S826
页数：1
相关论文
共 50 条
  • [31] Bevacizumab plus Weekly Paclitaxel with or Without Carboplatin for Previously-treated Non-squamous Non-Small Cell Lung Cancer
    Hata, Akito
    Katakami, Nobuyuki
    Tanaka, Kosuke
    Takeshita, Jumpei
    Matsumoto, Takeshi
    Monden, Kazuya
    Nagata, Kazuma
    Masago, Katsuhiro
    Kaji, Reiko
    Fujita, Shiro
    Tachikawa, Ryo
    Otsuka, Kyoko
    Otsuka, Kojiro
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (1A) : 275 - 281
  • [32] Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
    Jones, Benjamin S.
    Jerome, Mary S.
    Miley, Deborah
    Jackson, Bradford E.
    DeShazo, Mollie R.
    Reddy, Vishnu V. B.
    Singh, Karan P.
    Brown, Olivia C.
    Robert, Francisco
    LUNG CANCER, 2017, 106 : 125 - 130
  • [33] A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer
    Villaruz, Liza C.
    Cobo, Manuel
    Syrigos, Konstantinos
    Mavroudis, Dimitrios
    Zhang, Wei
    Kim, Jong Seok
    Socinski, Mark A.
    LUNG CANCER, 2019, 136 : 52 - 56
  • [34] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
    Yokoi, Takashi
    Torii, Yoshitaro
    Katashiba, Yuichi
    Sugimoto, Hiroyuki
    Tanijiri, Tsutomu
    Ogata, Makoto
    Inagaki, Noriko
    Kibata, Kayoko
    Hayashi, Mina
    Niki, Maiko
    Shimizu, Toshiki
    Miyara, Takayuki
    Kurata, Takayasu
    Nomura, Shosaku
    ONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457
  • [35] Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
    Ikeuchi, Nobumitsu
    Igata, Fumiyasu
    Kinoshita, Eriko
    Kawabata, Toshiaki
    Tan, Ibun
    Osaki, Yusuke
    Otsuka, Rikako
    On, Rintaro
    Ikeda, Takato
    Nakao, Akira
    Sasaki, Tomoya
    Aoyama, Takashi
    Hirano, Ryosuke
    Harada, Taishi
    Ebi, Noriyuki
    Fujita, Masaki
    Inoue, Hiroyuki
    ANTICANCER RESEARCH, 2023, 43 (02) : 713 - 724
  • [36] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer
    Masago, Katsuhiro
    Fujimoto, Daichi
    Fujita, Shiro
    Hata, Akito
    Kaji, Reiko
    Ohtsuka, Kyoko
    Okuda, Chiyuki
    Takeshita, Jumpei
    Katakami, Nobuyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 415 - 419
  • [38] Phase Ib clinical study of first-line treatment with gefitinib in combination with bevacizumab and chemotherapy in advanced non-squamous non-small cell lung cancer with EGFR mutation.
    Xiong, Yanjuan
    Ren, Xiubao
    Liu, Liang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer
    Yamaguchi, Teppei
    Hida, Toyoaki
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (08) : E11 - E14
  • [40] Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
    Tamiya, Akihiro
    Tamiya, Motohiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Kawamura, Takahisa
    Kunimasa, Kei
    Inoue, Takako
    Nishino, Kazumi
    Okishio, Kyoichi
    ANTICANCER RESEARCH, 2023, 43 (03) : 1325 - 1330
12345